Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 26 Artikel )

30.03.2019 | Review | Ausgabe 3/2019

Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis

Yasmin Korzets, Anthony Fyles, Daniel Shepshelovich, Eitan Amir, Hadar Goldvaser

01.04.2019 | Review | Ausgabe 3/2019

Applying a value-based care framework to post-mastectomy reconstruction

Clifford C. Sheckter, Evan Matros, Gordon K. Lee, Jesse C. Selber, Anaeze C. Offodile II

09.03.2019 | Preclinical study | Ausgabe 3/2019

Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer

Jilai Tian, Xiang Chen, Shengling Fu, Ruijie Zhang, Li Pan, Yang Cao, Xiaojuan Wu, Hui Xiao, Huey-Jen Lin, Hui-Wen Lo, Ying Zhang, Jiayuh Lin

01.04.2019 | Preclinical study | Ausgabe 3/2019

4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion

Gen Wang, Sisi Qin, Jacqueline Zayas, James N. Ingle, Mohan Liu, Richard M. Weinshilboum, Kunwei Shen, Liewei Wang

06.03.2019 | Clinical trial | Ausgabe 3/2019

What does risk of future cancer mean to breast cancer patients?

Karen Kaiser, Kenzie A. Cameron, Jennifer Beaumont, Sofia F. Garcia, Leilani Lacson, Margaret Moran, Lindsey Karavites, Chiara Rodgers, Swati Kulkarni, Nora M. Hansen, Seema A. Khan

07.03.2019 | Clinical trial | Ausgabe 3/2019

Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia

Gaber Plavc, Ivica Ratoša, Tina Žagar, Vesna Zadnik

09.03.2019 | Clinical trial | Ausgabe 3/2019 Open Access

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

F. Lynce, A. Barac, X. Geng, C. Dang, A. F. Yu, K. L. Smith, C. Gallagher, P. R. Pohlmann, R. Nunes, P. Herbolsheimer, R. Warren, M. B. Srichai, M. Hofmeyer, A. Cunningham, P. Timothee, F. M. Asch, A. Shajahan-Haq, M. T. Tan, C. Isaacs, S. M. Swain

13.03.2019 | Clinical trial | Ausgabe 3/2019 Open Access

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

A. F. de Groot, E. J. Blok, A. Charehbili, C. C. Engels, V. T. H. B. M. Smit, N. G. Dekker-Ensink, H. Putter, E. Meershoek-Klein Kranenbarg, C. J. H. van de Velde, G. J. Liefers, J. W. R. Nortier, P. J. K. Kuppen, S. H. van der Burg, J. R. Kroep

13.03.2019 | Clinical Trial | Ausgabe 3/2019

Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer

Peter A. Fasching, Paul Gass, Lothar Häberle, Bernhard Volz, Alexander Hein, Carolin C. Hack, Michael P. Lux, Sebastian M. Jud, Arndt Hartmann, Matthias W. Beckmann, Dennis J. Slamon, Ramona Erber

21.03.2019 | Clinical trial | Ausgabe 3/2019

Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial

Rafael J. A. Cámara, Lukas Schwentner, Thomas W. P. Friedl, Miriam Deniz, Visnja Fink, Krisztian Lato, Peter Widschwendter, Brigitte Rack, Wolfgang Janni, Susanne Singer, Inga Bekes

26.03.2019 | Clinical trial | Ausgabe 3/2019 Open Access

Two-year follow-up of the OptiTrain randomised controlled exercise trial

Kate A. Bolam, Sara Mijwel, Helene Rundqvist, Yvonne Wengström

27.03.2019 | Clinical trial | Ausgabe 3/2019

Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer

Kayla M. Daniell, Aditya Bardia, Fangdi Sun, Sacha A. Roberts, Cheryl L. Brunelle, Tessa C. Gillespie, Hoda E. Sayegh, George E. Naoum, Dejan Juric, Steven J. Isakoff, Donna M. Fitzgerald, Alphonse G. Taghian

01.04.2019 | Clinical trial | Ausgabe 3/2019

Efficacy and safety of taxane plus anthracycline with or without cyclophosphamide in Chinese node-positive breast cancer patients: an open-label, randomized controlled trial

Yan Lin, Changjun Wang, Xin Huang, Xingtong Zhou, Yidong Zhou, Feng Mao, Jinghong Guan, Yu Song, Ying Zhong, Ying Xu, Qiang Sun

05.03.2019 | Epidemiology | Ausgabe 3/2019

Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population

K. Clifton, Yi Min, J. Kimmel, J. Litton, D. Tripathy, M. Karuturi

09.03.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network

Elizabeth A. Chrischilles, Danielle Riley, Elena Letuchy, Linda Koehler, Joan Neuner, Cheryl Jernigan, Brian Gryzlak, Neil Segal, Bradley McDowell, Brian Smith, Sonia L. Sugg, Jane M. Armer, Ingrid M. Lizarraga

13.03.2019 | Epidemiology | Ausgabe 3/2019

Integrating of genomic and transcriptomic profiles for the prognostic assessment of breast cancer

Chengxiao Yu, Na Qin, Zhening Pu, Ci Song, Cheng Wang, Jiaping Chen, Juncheng Dai, Hongxia Ma, Tao Jiang, Yue Jiang

13.03.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project

Norbert Marschner, Tanja Trarbach, Jacqueline Rauh, Dirk Meyer, Sigrun Müller-Hagen, Johanna Harde, Stephanie Dille, Lisa Kruggel, Martina Jänicke, The TMK-Group (Tumour Registry Breast Cancer)

14.03.2019 | Epidemiology | Ausgabe 3/2019

Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study

Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman, Tove Filtenborg Tvedskov

16.03.2019 | Epidemiology | Ausgabe 3/2019

Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: a cohort study

Laura E. Davis, Courtney Fulton, Lev D. Bubis, Jonathan Sussman, Lesley Moody, Lisa Barbera, Qing Li, Alyson L. Mahar, Natalie G. Coburn, Claire M. B. Holloway

18.03.2019 | Epidemiology | Ausgabe 3/2019

Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain

Rebeca Font, Josep Alfons Espinas, Agustí Barnadas, Angel Izquierdo, Jaume Galceran, Francina Saladie, Rafael Marcos-Gragera, Abigail Torrent, Paula Manchon-Walsh, Josep M. Borras

20.03.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes

Mayu Hosio, Elina Urpilainen, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund, Ulla Puistola, Esa Läärä, Arja Jukkola, Peeter Karihtala

20.03.2019 | Epidemiology | Ausgabe 3/2019

Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China

Wei Cao, Yuntao Xie, Yingjian He, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Tao Ouyang

26.03.2019 | Epidemiology | Ausgabe 3/2019

Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001–2015)

Sarah J. Aurit, Susan S. Devesa, Amr S. Soliman, Catherine Schairer

01.04.2019 | Epidemiology | Ausgabe 3/2019

Body mass index impacts infection rates in immediate autogenous breast reconstruction

Lauren I. Willoughby, Josephine A. D’Abbondanza, Healther L. Baltzer, James L. Mahoney, Melinda A. Musgrave

07.03.2019 | Brief Report | Ausgabe 3/2019

Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer

Bingnan Zhang, Elisa F. Long

11.03.2019 | Brief Report | Ausgabe 3/2019

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy

Nicholas B. Figura, Victoria T. Rizk, Homan Mohammadi, Brittany Evernden, Sepideh Mokhtari, H. Michael Yu, Timothy J. Robinson, Arnold B. Etame, Nam D. Tran, James Liu, Iman Washington, Roberto Diaz, Brian J. Czerniecki, Hatem Soliman, Hyo S. Han, Solmaz Sahebjam, Peter A. Forsyth, Kamran A. Ahmed

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.